Professional Documents
Culture Documents
( )
/
.
(..)
-
-
-
-
-
-
- /
- /
-
-
-
-
-
-
-/ -/
/
-/ -/ -/
-/ -/ -/
-/ -/ -/
(Pharmaceutical Care Clerkship)
.
/
/
/
. /
.
.
.
.
.
.
(active
learning)
. /
.
/
. / /
.
.
/
. /
/
. /
/
/
) ,
(active learning)
(problem-based learning)
(experiential learning)
/ (project)
/
/
.
.
..
.. /
..
/
.. /
( )
.
..
.. /
.
-
-
. /
. /
-
-
-
-
-
- / /
/
. /
( )
. /
. /
. / (professional skill)
active learning (
/ ) passive learning
. / /
/
(
)
. / /
/
. /
/
. /
/
. /
. /
. /
/
. /
/
. //
. /
. /
. /
/
(Pharmaceutical Care Clerkship in asthma/COPD clinic)
.
/
.
.
. /
. /
.
.
,
GINA 2013
.
mmRC CAT score
GOLD 2013
. (acute
exacerbation)
.
.
/
/
.
.
. /
.
/
.
.
.
.
.
.
.
.
/
.
.
.
.
.
-
/*
-
/
-
/
-
-
-
/
- (journal club)
/
-
/
- (academic in-service)
-
/
-
-
-
-
: *
.
..
..
..
.
.. (-/, -/)
..
(-/, -/ -/)
..
... (Formal case presentation)
... (Academic in-service)
... (Journal Club)
:
-
. > /*
(refilling
system)
-/
-/
. > /
-/
()
. > /
(case
discussion)**
. (formal case presentation) >
-/
-/
-/
. /
>
-
(academic in-service)
. (Journal club)
>
-/
-/
-/
*
** case discussion
................................................................................................................................................
...................................................................................................................................
.
.
.
.
.
.
(refilling system)
()
(case
discussion)**
(formal case presentation)
(academic inservice)
(journal club)
> /*
> /
> /
>
>
>
: *
/
....................................................................................................................................
.......................................................................................................................................................................................
.......................................................................................................................................................................................
.......................................................................
..........................................
--/
/
/...........................................................................................................
................................................................................................................
/
/
(x)
/ ()
/
/
--/
/
/.............................................................................................................
..................................................................................................................
. (
)
.
.
.
. (
)
.
.
.
.
. (
)
. (
)
. (
)
( x )/
/...............................................................................................................................................
.....................................................................................................................................................................................................
.....................................................................................................................................................................................................
.....................................................
(......................................................)
--/
/.........................................................................................................
..............................................................................................................
/
/
(x) /
()
/ /
/ /
/ /
//
//
--/
/...........................................................................................................
................................................................................................................
N/A N/A
.
. ( //
)
. /
.
.
.
. (/
)
.
()
/
.
(subjective & objective data)
.
..
..
(Indication, Efficacy, Safety, Adherence,
Cost)
..
.. /
..
.
..
..
..
.. ///
--/
N/A N/A
.
. /
.
.
.
.
.
.. : pharmacist note,
.. :
.
.
. /
/
( x )/
/.......................................................................................................................................
.............................................................................................................................................................................................
.............................................................................................................................................................................................
.....................................................
(
)
--/
/..........................................................................................................
...............................................................................................................
(x)
/ ()
/
/
(critical point)
/ /
--/
/....................................................................................................
................................................................................................. .........
.
. CC, HPI, PMH, FH, SH, ALL, MH, PE, Lab
.
( x .)/
.
. /
.
(subjective & objective data)
.
..
..
.. (IESAC)
.
..
..
..
.. / ///
( x )/
.
.
( x .)/
.
.
.
. :
( x . )/
N/A
--/
.
. / Pharm D.
.
( x .)/
.
( x )/
( x )/
N/A
/.................................................................................................................................
......................................................................................................................................................................................
......................................................................................................................................................................................
.....................................................
(......................................................)
--/
/ ................................................................................................................
................................................................................... .......................................................
(x)
/ ()
--/
. /
/
/
.
.
.
.
..
.. /
.. / (drop out)
..
-
-
-
..
..
.. (outcome variables & outcome
measurement)
.
.
-
-
-
- /
. /
/
.
.
.
.
N/
A
--/
.:
.
.
/ Pharm D.
.
( x /) /
N/A
/...........................................................................................................................................
.............................................................................................................................................................................................
.............................................................................................................................................................................................
.....................................................
(......................................................)
--
/ ............................................................................. .....................................
...............................................................................................................................................
.
.
.
.
.
.
.
.
.
.
.
.
. :
.
.
. /
Pharm D.
.
( x )/
N/A
/..................................................................................................................................
.......................................................................................................................................................................................
.......................................................................................................................................................................................
.....................................................
(......................................................)
........................................... ..
(demographic of requestor)
.........................................................................................................................................................
................................................
. ............................................... ..........................E-mail address ......................
/
/
............................................................................................................................
(patient-specific question)
......................................................
...............................................................................................................................................
..............................................................................................................................................
.........................................
/
e-mail
website/webboard ....................................................................
(request)
(initial question)
..
..
(background information)
..
..
..
..
(ultimate question)
..
..
.
. .....................................
.............................................................................................................................................
.............................................................................................................................................................
. .....................................
.............................................................................................................................................
.............................................................................................................................................................
.
. .....................................
.............................................................................................................................................
.
. .....................................
.............................................................................................................................................
.
.
. .....................................
.............................................................................................................................................
.
. .....................................
.............................................................................................................................................
.
.
. .....................................
.............................................................................................................................................
.
. .....................................
.............................................................................................................................................
.
(keywords)
.
.
.
.
.
.
.
.
.
. ...
.......................................................................................
. ...
.......................................................................................
. ...
.......................................................................................
/
e-mail
web site / web board
............................................................................
.. .
..............................................................